422 related articles for article (PubMed ID: 4902224)
1. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Inoue J; Mori Y; Kawamura T
Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
[No Abstract] [Full Text] [Related]
2. Ascites formation in cirrhosis and its management.
Sherlock S
Scand J Gastroenterol Suppl; 1970; 7():9-15. PubMed ID: 4917041
[No Abstract] [Full Text] [Related]
3. [Pathogenesis and therapy of ascites in hepatic cirrhosis].
Persico L
Policlinico Prat; 1971 Feb; 78(3):100-9. PubMed ID: 5572866
[No Abstract] [Full Text] [Related]
4. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
Cavatorta F; Queirolo C; Brignole M; Zangani F
Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
[No Abstract] [Full Text] [Related]
5. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Arbeiter G; Meyer-Burg J
Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
[No Abstract] [Full Text] [Related]
6. A new approach for refractory oedema--pharmacological paracentesis.
Sonwalkar AV; Wechalekar MD; Wechalekar DK; Waikar SM; Bhala BB
J Assoc Physicians India; 1973 Jul; 21(7):585-8. PubMed ID: 4283774
[No Abstract] [Full Text] [Related]
7. The rational management of ascites.
Conn HO
Prog Liver Dis; 1972; 4():269-88. PubMed ID: 4581860
[No Abstract] [Full Text] [Related]
8. [Saluretics in liver diseases].
Dorner M; Frey G
Munch Med Wochenschr; 1966 Dec; 108(51):2583-4. PubMed ID: 6013308
[No Abstract] [Full Text] [Related]
9. [Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy].
Spech HJ
Fortschr Med; 1979 Apr; 97(15):714-8. PubMed ID: 456975
[TBL] [Abstract][Full Text] [Related]
10. Management of ascites and renal failure in cirrhosis.
Forns X; Ginès A; Ginès P; Arroyo V
Semin Liver Dis; 1994 Feb; 14(1):82-96. PubMed ID: 8016665
[No Abstract] [Full Text] [Related]
11. The pathogenesis of cirrhotic ascites.
Falaiye JM
Niger Med J; 1978 Sep; 8(5):438-42. PubMed ID: 366957
[No Abstract] [Full Text] [Related]
12. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Lowenthal DT; Shear L
Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
[No Abstract] [Full Text] [Related]
13. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
Naika; 1971; 28(1):163-7. PubMed ID: 5565686
[No Abstract] [Full Text] [Related]
14. Use of diuretics in heart failure and cirrhosis.
Schrier RW
Semin Nephrol; 2011 Nov; 31(6):503-12. PubMed ID: 22099507
[TBL] [Abstract][Full Text] [Related]
15. Influence of mechanical factors on ascites formation in hepatic cirrhosis.
Witte MH; Witte CL
Lymphology; 1969 Sep; 2(3):89-91. PubMed ID: 5357967
[No Abstract] [Full Text] [Related]
16. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
Stanley AJ; Bouchier IA; Hayes PC
Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
[TBL] [Abstract][Full Text] [Related]
17. Amiloride. A potassium-sparing natriuretic agent.
Bull MB; Laragh JH
Circulation; 1968 Jan; 37(1):45-53. PubMed ID: 5634728
[No Abstract] [Full Text] [Related]
18. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
Schwartz M; Fodor O
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(3):219-25. PubMed ID: 770
[No Abstract] [Full Text] [Related]
19. [Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
Loginov AS; Berezov VM
Ter Arkh; 1967 Aug; 39(8):12-20. PubMed ID: 4890954
[No Abstract] [Full Text] [Related]
20. [Clinical application of diuretics: ascites].
Kato E; Higashi F
Nihon Rinsho; 1984 Sep; 42(9):2051-6. PubMed ID: 6394799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
